Outcomes of Complicated CL in Ethiopia Treated With Miltefosine

Status Completed

Clinical Trial Summary

Cutaneous Leishmaniasis in Ethiopia causes severe dermatological mutilations. Forms that require systemic treatment are cLCL, MCL, and DCL. National guidelines recommend equally all drugs that are also used for VL treatment. Miltefosine is one of these recommended medications but remains underused due to scarcity of drugs.

Outcomes of patients receiving miltefosine have never been documented systematically in Ethiopia until today. This is needed to provide evidence to advocate for increased access to miltefosine in Ethiopia, and to establish baseline data for future research on CL treatment options. The aim of this study is to document treatment outcomes of patients with cLCL, MCL, and DCL receiving systemic treatment using miltefosine within a routine care setting located in an endemic area in Ethiopia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04004754
Study type	Observational
Source	Institute of Tropical Medicine, Belgium
Contact
Status	Completed
Phase
Start date	May 7, 2019
Completion date	June 11, 2020

View Details

See also
Status	Clinical Trial	Phase
Suspended	`NCT03292835` - Complex Cutaneous Leishmaniasis Healing Study in Algeria
Terminated	`NCT03208543` - Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan	Phase 3
Completed	`NCT04512742` - A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies	N/A
Active, not recruiting	`NCT05332093` - Spatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
Active, not recruiting	`NCT04515186` - Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World	Phase 3
Completed	`NCT02919605` - Efficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis	Phase 2
Completed	`NCT03837431` - Cutaneous Leishmaniasis Diagnostic Study
Not yet recruiting	`NCT05493059` - Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
Terminated	`NCT04001335` - Diagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium
Completed	`NCT03929016` - Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects	Phase 1
Completed	`NCT03435419` - Evaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan	N/A